Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("BURNETT, Alan K")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 97

  • Page / 4
Export

Selection :

  • and

Treatment of acute myeloid leukaemia in younger patientsBURNETT, Alan K.Baillière's best practice & research. Clinical haematology. 2001, Vol 14, Num 1, pp 95-118, issn 1521-6926Article

Acute myeloid leukaemiaBURNETT, Alan K.Baillière's best practice & research. Clinical haematology. 2001, Vol 14, Num 1, issn 1521-6926, 236 p.Serial Issue

Modern management of acute myeloid leukemiaBURNETT, Alan K.Seminars in hematology. 2001, Vol 38, Num 3, issn 0037-1963, 32 p., SUP6Serial Issue

New induction and postinduction strategies in acute myeloid leukemiaBURNETT, Alan K.Current opinion in hematology. 2012, Vol 19, Num 2, pp 76-81, issn 1065-6251, 6 p.Article

Managing therapy in older adult patients with acute myeloid leukemiaLÖWENBERG, Bob.Seminars in hematology. 2001, Vol 38, Num 3, pp 10-16, issn 0037-1963, SUP6Article

Prognostic factors in acute myeloid leukaemiaLÖWENBERG, Bob.Baillière's best practice & research. Clinical haematology. 2001, Vol 14, Num 1, pp 65-75, issn 1521-6926Article

Current status and perspectives of therapy for acute myeloid leukemiaHIDDEMANN, Wolfgang; BÜCHNER, Thomas.Seminars in hematology. 2001, Vol 38, Num 3, pp 3-9, issn 0037-1963, SUP6Article

Chemotherapy resistance in acute myeloid leukaemiaSONNEVELD, Pieter; LIST, Alan F.Baillière's best practice & research. Clinical haematology. 2001, Vol 14, Num 1, pp 211-233, issn 1521-6926Article

Current use and future development of gemtuzumab ozogamicinLARSON, Richard A.Seminars in hematology. 2001, Vol 38, Num 3, pp 24-31, issn 0037-1963, SUP6Article

Role of allogeneic and autologous hematopoietic stem cell transplantation in acute myeloid leukemiaBURNETT, Alan K; KELL, Jonathan; ROWNTREE, Clare et al.International journal of hematology. 2000, Vol 72, Num 3, pp 280-284, issn 0925-5710Article

Molecular genetics of acute myeloid leukaemiaDASH, Ajeeta; GILLILAND, D. Gary.Baillière's best practice & research. Clinical haematology. 2001, Vol 14, Num 1, pp 49-64, issn 1521-6926Article

Postremission therapy in adults with acute myeloid leukemiaSTONE, Richard M.Seminars in hematology. 2001, Vol 38, Num 3, pp 17-23, issn 0037-1963, SUP6Article

Growth factors in acute myeloid leukaemiaESTEY, Elihu H.Baillière's best practice & research. Clinical haematology. 2001, Vol 14, Num 1, pp 175-187, issn 1521-6926Article

Toward Better Therapies of Leukemias, Myelodysplastic Syndrome, and Myeloproliferative DisordersSCHIFFER, Charles A; BURNETT, Alan K.Journal of clinical oncology. 2011, Vol 29, Num 5, issn 0732-183X, 131 p.Serial Issue

Treatment of older patients with acute myeloid leukemia : New agentsBURNETT, Alan K; MOHITE, Unmesh.Seminars in hematology. 2006, Vol 43, Num 2, pp 96-106, issn 0037-1963, 11 p.Article

Prognosis of myelodysplasic patients: non-parametric multiple regression analysis of populations stratified by mean corpuscular volume and marrow myeloblast numberTENNANT, Graham B; AL-SABAH, Ala I; BURNETT, Alan K et al.British journal of haematology. 2002, Vol 119, Num 1, pp 87-96, issn 0007-1048, 10 p.Article

Myeloproliferative Neoplasms: Molecular Pathophysiology, Essential Clinical Understanding, and Treatment StrategiesTEFFERI, Ayalew; VAINCHENKER, William.Journal of clinical oncology. 2011, Vol 29, Num 5, pp 573-582, issn 0732-183X, 10 p.Article

Gemtuzumab ozogamicinAPPELBAUM, Frederick R; BURNETT, Alan K; GROSSBARD, Michael L et al.Drugs (Basel). 2001, Vol 61, Num 9, pp 1323-1324, issn 0012-6667Article

Treatment of acute promyelocytic leukaemiaFENAUX, Pierre; CHOMIENNE, Christine; DEGOS, Laurent et al.Baillière's best practice & research. Clinical haematology. 2001, Vol 14, Num 1, pp 153-174, issn 1521-6926Article

Clinical importance of cytogenetics in acute myeloid leukaemiaMROZEK, Krzysztof; HEINONEN, Kristiina; BLOOMFIELD, Clara D et al.Baillière's best practice & research. Clinical haematology. 2001, Vol 14, Num 1, pp 19-47, issn 1521-6926Article

Laboratory diagnosis of acute myeloid leukaemiaSWIRSKY, David Michael; RICHARDS, Stephen John.Baillière's best practice & research. Clinical haematology. 2001, Vol 14, Num 1, pp 1-17, issn 1521-6926Article

Modern Therapy of Acute Lymphoblastic LeukemiaBASSAN, Renato; HOELZER, Dieter.Journal of clinical oncology. 2011, Vol 29, Num 5, pp 532-543, issn 0732-183X, 12 p.Article

The role of PKC and PDK1 in monocyte lineage specification by RasPEARN, Lorna; FISHER, Janet; BURNETT, Alan K et al.Blood. 2007, Vol 109, Num 10, pp 4461-4469, issn 0006-4971, 9 p.Article

Biology and therapy of secondary leukaemiasDANN, Eldad J; ROWE, Jacob M.Baillière's best practice & research. Clinical haematology. 2001, Vol 14, Num 1, pp 119-137, issn 1521-6926Article

Molecular Genetics of Adult Acute Myeloid Leukemia: Prognostic and Therapeutic ImplicationsMARCUCCI, Guido; HAFERLACH, Torsten; DÖHNER, Hartmut et al.Journal of clinical oncology. 2011, Vol 29, Num 5, pp 475-486, issn 0732-183X, 12 p.Article

  • Page / 4